Kaken Pharmaceutical Co., Ltd. (4521.T) JPX

4,125.00

+40(+0.98%)

Updated at December 25 03:30PM

Currency In JPY

Valuation

Market Cap171B
Enterprise Value120.76B
P/E Ratio239.95
PEG Ratio-2.56
Price/Sales Ratio1.9
Price/Book Ratio1.06
Enterprise/Revenue1.4
Enterprise/EBITDA24.5

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.01
Operating Margin0.02

Management Effectiveness

Return On Assets0
Return On Equity0

Income Statement

Revenue94.04B
Revenue/Share2,165.89
Gross Profit58.26B
EBITDA22.02B
Net Income13.95B
Diluted EPS365.42

Balance Sheet

Total Cash57.1B
Total Cash/Share1,507.96
Total Debt3.85B
Total Debt/Equity0.03
Current Ratio4.4
Book Value Per Share3,903.01

Price History

52-Week Change-1.13
52-Week High4,901
52-Week Low3,540
Moving Average 50 Days3,781
Moving Average 200 Days3,925.82

Statistics

Average Volume172,396
Shares Outstanding37.87M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate170
Trailing Annual Dividend Yield4.12
Payout Ratio0
Last Split Factor1:2
Last Split DateSeptember 28, 2015